Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Durand-Zaleski, I
498  Ergebnisse:
?
1

HSD117 Healthcare Resources Utilization (HCRU) and Explorat..:

Durand-Zaleski, I. ; Albigès, L. ; Branchoux, S....
Value in Health.  26 (2023)  12 - p. S316 , 2023
Link: https://doi.org/10.1016/..
 
?
2

OP16_8. Impact of first-trimester preeclampsia screening on..:

Tsatsaris, V. ; Deneux, C. ; Guibourdenche, J....
Pregnancy Hypertension.  33 (2023)  - p. e85 , 2023
Link: https://doi.org/10.1016/..
 
?
3

HPR191 Incentives for Using Biosimilars in France and Europ..:

Tuvi, C. ; Wateau, P. ; Thomas, T..
Value in Health.  26 (2023)  12 - p. S287 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Cost-effectiveness of geriatric assessment for reducing tre..:

Serrano, A. Gonzalez ; Zarca, K. ; Durand-Zaleski, I....
Journal of Geriatric Oncology.  14 (2023)  8 - p. S3-S4 , 2023
Link: https://doi.org/10.1016/..
 
?
5

RWD36 Immunoglobulin Use in France 2015 to 2022–Real-World ..:

Darlington, M. ; Paulin, L. ; Ngaleu Siaha, B.F...
Value in Health.  26 (2023)  12 - p. S511 , 2023
Link: https://doi.org/10.1016/..
 
?
6

EE63 Cost-Effectiveness of Olaparib Plus Bevacizumab First-..:

Perrier, L. ; Zarca, K. ; Cadet, T....
Value in Health.  26 (2023)  12 - p. S61-S62 , 2023
Link: https://doi.org/10.1016/..
 
?
7

RWD112 Factors Associated with High Costs of Patients with ..:

Arnaud, N.O. ; Brzustowski, A. ; Paradis, V....
Value in Health.  26 (2023)  12 - p. S525 , 2023
Link: https://doi.org/10.1016/..
 
?
8

HSD101 Policy Analysis of Eight Failed Telemedicine Experim..:

Le Bras, A ; Zarca, K ; Mimouni, M.
Value in Health.  25 (2022)  12 - p. S292 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Épidémiologie et fardeau de la drépanocytose en France : an..:

Cissé, O. Alfa ; Durand-Zaleski, I. ; Pirenne, F....
La Revue de Médecine Interne.  43 (2022)  - p. A444-A445 , 2022
Link: https://doi.org/10.1016/..
 
?
10

EPH122 Healthcare Consumptions in Patient with Early Ageing..:

Vimont, A ; Leleu, H ; Durand-Zaleski, I
Value in Health.  25 (2022)  12 - p. S214 , 2022
Link: https://doi.org/10.1016/..
 
?
11

EE179 Cost-Effectiveness of Robot-Assisted Total Hysterecto..:

Vappereau, A ; Paul-Dehlinger, R ; Le Bras, A...
Value in Health.  25 (2022)  12 - p. S88 , 2022
Link: https://doi.org/10.1016/..
 
?
12

EPH47 Early Hospital Management of Ageing Disease: Retrospe..:

Vimont, A ; Leleu, H ; Durand-Zaleski, I
Value in Health.  25 (2022)  12 - p. S200 , 2022
Link: https://doi.org/10.1016/..
 
?
13

HPR47 Comparison of the Characteristics and Costs of Vulner..:

Zarca, K ; Feral Pierssens, AL ; Durand-Zaleski, I.
Value in Health.  25 (2022)  12 - p. S241 , 2022
Link: https://doi.org/10.1016/..
 
?
14

CO103 Prognostic Models for Short-Term Annual Risk of Sever..:

Vimont, A ; Béliard, S ; Valéro, R..
Value in Health.  25 (2022)  12 - p. S38 , 2022
Link: https://doi.org/10.1016/..
 
?
15

EE99 Cost-Effectiveness of Percutaneous Closure of a Patent..:

Darlington, M ; Gaston, Y ; Charles-Nelson, A...
Value in Health.  25 (2022)  12 - p. S72 , 2022
Link: https://doi.org/10.1016/..
 
1-15